Biological evaluation of Fe 3O 4-poly(l-lactide)-poly(ethylene glycol)-poly(l-lactide) magnetic microspheres prepared in supercritical CO 2

Toxicology Letters

Volumn 212, Issue 1, 2012, Pages 75-82

  Chen, Ai Zheng ^a   Lin, Xiao Fen ^a   Wang, Shi Bin ^a   Li, Li ^a   Liu, Yuan Gang ^a   Ye, Li ^a   Wang, Guang Ya ^a  

^a HUAQIAO UNIVERSITY   (China)

Author keywords

Biocompatibility; Fe 3O 4; Magnetic microspheres; PLLA PEG PLLA; Supercritical CO 2

Indexed keywords

CARBON DIOXIDE; FERRIC OXIDE; MACROGOL; MAGNETIC NANOPARTICLE; MESSENGER RNA; MICROSPHERE; POLYLACTIDE; POLYMER; REACTIVE OXYGEN METABOLITE;

ACUTE TOXICITY; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CHO CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE; FEMALE; GENOTOXICITY; HEMOLYSIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPERCRITICAL FLUID; SUSPENSION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CHO CELLS; CRICETINAE; CYTOKINES; DNA DAMAGE; ERYTHROCYTES; FEMALE; FERRIC COMPOUNDS; HUMANS; LACTATES; MALE; MICE; MICRONUCLEUS TESTS; MICROSPHERES; POLYETHYLENE GLYCOLS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA; YOUNG ADULT;

EID: 84861558531     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.05.009     Document Type: Article

References (40)

1. Ahamed M., Karns M., Goodson M., Rowe J., Hussain S.M., Schlager J.J., Hong Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicology and Applied Pharmacology 2008, 233:404-410.
2. Aqil A., Vasseur S., Duguet E., Passirani C., Benoit J.P., Roch A., Muller R., Jerome R., Jerome C. PEO coated magnetic nanoparticles for biomedical application. European Polymer Journal 2008, 44:3191-3199.
3. Baselt D.R., Lee G.U., Natesan M., Metzger S.W., Sheehan P.E., Colton R.J. A biosensor based on magnetoresistance technology. Biosensors and Bioelectronics 1998, 13:731-739.
4. Berry C.C., Wells S., Charles S., Curtis A.S.G. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003, 24:4551-4557.
5. Brayner R. The toxicological impact of nanoparticles. Nano Today 2008, 3:48-55.
6. Chou L., Firth J.D., Uitto V.J., Brunette D.M. Substratum surface topography alters cell shape and regulates fibronectin mRNA level, mRNA stability, secretion and assembly in human fibroblasts. Journal of Cell Science 1995, 108(Pt 4):1563-1573.
7. Evanochko W.T., Ng T.C., Glickson J.D. Application of in vivo NMR spectroscopy to cancer. Magnetic Resonance in Medicine 1984, 1:508-534.
8. Fenech M. Cytokinesis-block micronucleus cytome assay. Nature Protocols 2007, 2:1084-1104.
9. Fischer H.C., Chan W.C.W. Nanotoxicity: the growing need for in vivo study. Current Opinion in Biotechnology 2007, 18:565-571.
10. Gu H.W., Xu K.M., Xu C.J., Xu B. Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chemical Communications 2006, 941-949.
11. Gupta A.K., Berry C., Gupta M., Curtis A. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Transactions on Nanobioscience 2003, 2:255-261.
12. Gupta A.K., Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 2005, 26:1565-1573.
13. Hafeli U.O., Pauer G.J. In vitro and in vivo toxicity of magnetic microspheres. Journal of Magnetism and Magnetic Materials 1999, 194:76-82.
14. Hesterberg T.W., Butterick C.J., Oshimura M., Brody A.R., Barrett J.C. Role of phagocytosis in Syrian hamster cell transformation and cytogenetic effects induced by asbestos and short and long glass fibers. Cancer Research 1986, 46:5795-5802.
15. Hohnholt M.C., Geppert M., Dringen R. Treatment with iron oxide nanoparticles induces ferritin synthesis but not oxidative stress in oligodendroglial cells. Acta Biomaterialia 2011, 7:3946-3954.
16. Karlsson H.L., Gustafsson J., Cronholm P., Moller L. Size-dependent toxicity of metal oxide particles-a comparison between nano- and micrometer size. Toxicology Letters 2009, 188:112-118.
17. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., Song I.C., Moon W.K., Hyeon T. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angewandte Chemie International Edition 2008, 47:8438-8441.
18. Kunzmann A., Andersson B., Vogt C., Feliu N., Ye F., Gabrielsson S., Toprak M.S., Buerki-Thurnherr T., Laurent S., Vahter M., Krug H., Muhammed M., Scheynius A., Fadeel B. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicology and Applied Pharmacology 2011, 253:81-93.
19. Lacava Z.G.M., Azevedo R.B., Martins E.V., Lacava L.M., Freitas M.L.L., Garcia V.A.P., Rebula C.A., Lemos A.P.C., Sousa M.H., Tourinho F.A., Da Silva M.F., Morais P.C. Biological effects of magnetic fluids: toxicity studies. Journal of Magnetism and Magnetic Materials 1999, 201:431-434.
20. Lawaczeck R., Bauer H., Frenzel T., Hasegawa M., Ito Y., Kito K., Miwa N., Tsutsui H., Vogler H., Weinmann H.J. Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Acta Radiologica 1997, 38:584-597.
21. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnology 2000, 18:410-414.
22. Liang Y.Y., Zhang L.M. Bioconjugation of papain on superparamagnetic nanoparticles decorated with carboxymethylated chitosan. Biomacromolecules 2007, 8:1480-1486.
23. Lindberg H.K., Falck G.C.M., Suhonen S., Vippola M., Vanhala E., Catalan J., Savolainen K., Norppa H. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicology Letters 2009, 186:166-173.
24. -ΔΔCT method. Methods 2001, 25:402-408.
25. Mu Q., Yang L., Davis J.C., Vankayala R., Hwang K.C., Zhao J., Yan B. Biocompatibility of polymer grafted core/shell iron/carbon nanoparticles. Biomaterials 2010, 31:5083-5090.
26. Muller K., Skepper J.N., Posfai M., Trivedi R., Howarth S., Corot C., Lancelot E., Thompson P.W., Brown A.P., Gillard J.H. Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials 2007, 28:1629-1642.
27. Pape W.J., Pfannenbecker U., Hoppe U. Validation of the red blood cell test system as in vitro assay for the rapid screening of irritation potential of surfactants. Molecular Toxicology 1987, 1:525-536.
28. Petri-Fink A., Chastellain M., Juillerat-Jeanneret L., Ferrari A., Hofmann H. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 2005, 26:2685-2694.
29. Pfaller T., Colognato R., Nelissen I., Favilli F., Casals E., Ooms D., Leppens H., Ponti J., Stritzinger R., Puntes V., Boraschi D., Duschl A., Oostingh G.J. The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events. Nanotoxicology 2010, 4:52-72.
30. Reer O., Bock T.K., Muller B.W. In vitro corneal permeability of diclofenac sodium in formulations containing cyclodextrins compared to the commercial product voltaren ophtha. Journal of Pharmaceutical Sciences 1994, 83:1345-1349.
31. Sagnella S., Mai-Ngam K. Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials. Colloids and Surfaces B 2005, 42:147-155.
32. Soenen S.J.H., Himmelreich U., Nuytten N., De Cuyper M. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 2011, 32:195-205.
33. Sun C., Sze R., Zhang M. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. Journal of Biomedical Materials Research Part B 2006, 78A:550-557.
34. Wagner S., Schnorr J., Pilgrimm H., Hamm B., Taupitz M. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging-preclinical in vivo characterization. Investigative Radiology 2002, 37:167-177.
35. Widder K.J., Senyei A.E., Ranney D.F. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. Cancer Research 1980, 40:3512-3517.
36. Yang P., Quan Z., Hou Z., Li C., Kang X., Cheng Z., Lin J. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier. Biomaterials 2009, 30:4786-4795.
37. Yeh C.H., Hsiao J.K., Wang J.L., Sheu F. Immunological impact of magnetic nanoparticles (Ferucarbotran) on murine peritoneal macrophages. Journal of Nanoparticle Research 2010, 12:151-160.
38. Yuk S.H., Oh K.S., Cho S.H., Lee B.S., Kim S.Y., Kwak B.K., Kim K., Kwon I.C. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging. Biomacromolecules 2011, 12:2335-2343.
39. Zhang J., Misra R.D.K. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer core-shell nanoparticle carrier and drug release response. Acta Biomaterialia 2007, 3:838-850.
40. Zhang Y., Kohler N., Zhang M.Q. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23:1553-1561.